Titan Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 0 | $1.54 | $1.54 | $1.54 |
Titan Pharmaceuticals, Inc. Earnings Date And Information
Titan Pharmaceuticals, Inc. last posted its earnings results on Monday, November 15th, 2021. The company reported $-3.8 earnings per share for the quarter, missing analysts' consensus estimates of $-0.35 by $3.45. The company had revenue of 0 for the quarter and had revenue of 184,000 for the year. Titan Pharmaceuticals, Inc. has generated $-7 earnings per share over the last year ($-7.41 diluted earnings per share) and currently has a price-to-earnings ratio of -0.93. Titan Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Titan Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/15/2024 | Q2 2024 | -$2.29 | $0 | $0 | ||
| 05/15/2024 | Q1 2024 | -$1.24 | $0 | |||
| 04/01/2024 | Q4 2023 | -$2.52 | $81,000 | |||
| 11/14/2023 | Q3 2023 | -$0.45 | $4,000 | |||
| 08/14/2023 | Q2 2023 | -$2.11 | $1,000 | |||
| 05/15/2023 | Q1 2023 | -$2.20 | $98,000 | |||
| 03/31/2023 | Q4 2022 | -$3.47 | $51,000 | |||
| 11/14/2022 | Q3 2022 | -$0.18 | $4,000 | |||
| 08/11/2022 | Q2 2022 | -$0.18 | $150,000 | |||
| 05/16/2022 | Q1 2022 | -$0.24 | $192,000 | |||
| 03/25/2022 | Q4 2021 | -$0.26 | $135,000 | |||
| 11/15/2021 | Q3 2021 | -$0.35 | -$0.19 | 0.16 | $1.09 M | $264,000 |
| 08/16/2021 | Q2 2021 | -$0.35 | -$0.17 | 0.18 | $1.00 M | $445,000 |
| 05/17/2021 | Q1 2021 | -$0.85 | -$0.28 | 0.57 | $682,000 | |
| 03/31/2021 | Q4 2020 | -$1.33 | -$0.33 | 1 | $1.06 M | |
| 11/16/2020 | Q3 2020 | -$24.02 | -$1.51 | 22.51 | $1.00 M | $1.12 M |
| 08/14/2020 | Q2 2020 | -$18.02 | -$1.47 | 16.55 | $823,000 | $1.33 M |
| 05/15/2020 | Q1 2020 | -$2.03 | $1.34 M | |||
| 03/30/2020 | Q4 2019 | -$0.08 | -$1.43 | -1.35 | $1.22 M | |
| 11/14/2019 | Q3 2019 | -$132.13 | -$5.42 | 126.71 | $929,000 | $947,000 |
Titan Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Titan Pharmaceuticals, Inc.'s earnings date?
Titan Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to Titan Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Titan Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Titan Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Titan Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Titan Pharmaceuticals, Inc. generate each year?
Titan Pharmaceuticals, Inc. (:TTNP) has a recorded annual revenue of $184,000.
-
How much profit does Titan Pharmaceuticals, Inc. generate each year?
Titan Pharmaceuticals, Inc. (:TTNP) has a recorded net income of $184,000. Titan Pharmaceuticals, Inc. has generated $-7.41 earnings per share over the last four quarters.
-
What is Titan Pharmaceuticals, Inc.'s price-to-earnings ratio?
Titan Pharmaceuticals, Inc. (:TTNP) has a price-to-earnings ratio of -0.93 and price/earnings-to-growth ratio is -0.02.
